Tianjin, China

Jinfang Hu

This inventor holds 1 USPTO granted patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinfang Hu. Retrieved from https://idiyas.com/inventor/jinfang-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinfang Hu: Innovator in Hepatic Fibrosis Treatment

Introduction

Jinfang Hu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of medicine, particularly in the treatment of hepatic fibrosis. His innovative approach utilizes natural ingredients to develop effective therapeutic solutions.

Latest Patents

Jinfang Hu holds a patent for the "Use of radix salviae miltiorrhizae (danshen) or its preparations in preparation of drugs for treating diseases related to hepatic fibrosis." This invention focuses on the application of Radix Salviae Miltiorrhizae, commonly known as Danshen, in creating drugs aimed at treating hepatic fibrosis. This patent highlights his commitment to advancing medical treatments through natural remedies.

Career Highlights

Throughout his career, Jinfang Hu has been associated with Tasly Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to explore innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the field.

Collaborations

Jinfang Hu has collaborated with notable colleagues, including Yonghong Zhu and Jie Ma. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Jinfang Hu's contributions to the treatment of hepatic fibrosis through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire future advancements in medical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…